IRCT138805172308N1已完成2 期
Effect of Silymarin on Non Alcoholic Steatohepatitis
Mazandaran University of Medical Sciences and Health Services0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 100 years（—）
- 性别
- All
入选标准
- •Including criteria: older than 20 years with nonalcoholic- fatty liver disease and liver enzymes> 50 and proportion of ALT/ AST> 1
- •Excluding criteria: using drugs that affect liver tests during the last 2 months, viral hepatitis, hemochromatosis, autoimmune hepatitis, cirrhosis, diabetes mellitus, alcohol dependency, pregnancy, breast feeding, and infectious diseases
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Evaluation of the effect of silymarin on hepatotoxicity induced by RemdesivirCOVID-19.COVID-19, virus identifiedU07.1IRCT20201227049854N1Shahre-kord University of Medical Sciences70
已完成
不适用
Effect of sylimarin in treatment of fatty livernon alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified Nonalcoholic fatty liver disease (NAFLD)IRCT2016080614882N4Vice Chancellor for Research of Shahrekord University of Medical Science16
已完成
不适用
Analysis of nonalcoholic steatohepatitis and the risk of cardiovascular event in terms of lipid metabolism abnormalityonalcoholic fatty liver diseaseJPRN-UMIN000009614Yokohama City University Graduate School of Medicine100
已完成
2 期
Treating Nonalcoholic Steatohepatitis (NASH) With MetforminHepatitisNCT00063232National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)28
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64